Total Payments
$60,050
2024 Payments
$51,134
Companies
18
Transactions
84
Medicare Patients
406
Medicare Billing
$88,248
Payment Breakdown by Category
Other$42,830 (71.3%)
Consulting$8,813 (14.7%)
Travel$5,504 (9.2%)
Food & Beverage$2,701 (4.5%)
Education$188.95 (0.3%)
Gifts$13.20 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $42,830 | 15 | 71.3% |
| Consulting Fee | $8,813 | 4 | 14.7% |
| Travel and Lodging | $5,504 | 13 | 9.2% |
| Food and Beverage | $2,701 | 49 | 4.5% |
| Education | $188.95 | 2 | 0.3% |
| Gift | $13.20 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Kite Pharma, Inc. | $40,672 | 34 | $0 (2024) |
| Incyte Corporation | $12,508 | 19 | $0 (2024) |
| CTI BioPharma Corp. | $3,192 | 2 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $1,607 | 4 | $0 (2024) |
| National Marrow Donor Program | $1,359 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $122.70 | 1 | $0 (2020) |
| PFIZER INC. | $120.97 | 1 | $0 (2017) |
| Janssen Scientific Affairs, LLC | $81.86 | 3 | $0 (2024) |
| Genmab U.S., Inc. | $58.35 | 2 | $0 (2024) |
| ABBVIE INC. | $54.63 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $51,134 | 53 | Kite Pharma, Inc. ($40,421) |
| 2023 | $8,175 | 20 | Incyte Corporation ($4,591) |
| 2022 | $159.64 | 6 | Pharmacyclics LLC, an AbbVie Company ($51.65) |
| 2020 | $122.70 | 1 | AstraZeneca Pharmaceuticals LP ($122.70) |
| 2017 | $458.10 | 4 | E.R. Squibb & Sons, L.L.C. ($337.13) |
All Payment Transactions
84 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Incyte Corporation | NIKTIMVO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $430.00 | General |
| Category: Oncology | ||||||
| 12/18/2024 | Incyte Corporation | JAKAFI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,440.00 | General |
| Category: Hematology/Oncology | ||||||
| 11/16/2024 | Incyte Corporation | JAKAFI (Drug) | Travel and Lodging | Cash or cash equivalent | $302.54 | General |
| Category: Hematology/Oncology | ||||||
| 11/16/2024 | Incyte Corporation | JAKAFI (Drug) | Travel and Lodging | Cash or cash equivalent | $300.96 | General |
| Category: Hematology/Oncology | ||||||
| 11/16/2024 | Incyte Corporation | JAKAFI (Drug) | Travel and Lodging | Cash or cash equivalent | $130.00 | General |
| Category: Hematology/Oncology | ||||||
| 11/16/2024 | Incyte Corporation | JAKAFI (Drug) | Travel and Lodging | Cash or cash equivalent | $130.00 | General |
| Category: Hematology/Oncology | ||||||
| 11/16/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $40.64 | General |
| Category: Hematology/Oncology | ||||||
| 11/16/2024 | Incyte Corporation | JAKAFI (Drug) | Travel and Lodging | Cash or cash equivalent | $26.00 | General |
| Category: Hematology/Oncology | ||||||
| 11/15/2024 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $136.11 | General |
| Category: CELLT | ||||||
| 11/14/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $31.01 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Incyte Corporation | JAKAFI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $430.00 | General |
| Category: Hematology/Oncology | ||||||
| 11/11/2024 | Kite Pharma, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,780.00 | General |
| 11/07/2024 | Kite Pharma, Inc. | — | Travel and Lodging | In-kind items and services | $634.74 | General |
| 11/07/2024 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $116.41 | General |
| 11/01/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Kite Pharma, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,210.00 | General |
| 10/24/2024 | Kite Pharma, Inc. | — | Travel and Lodging | In-kind items and services | $956.64 | General |
| 10/24/2024 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $95.05 | General |
| 10/23/2024 | Incyte Corporation | — | Education | Cash or cash equivalent | $89.00 | General |
| 10/14/2024 | Kite Pharma, Inc. | Yescarta (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,780.00 | General |
| Category: CELLT | ||||||
| 10/10/2024 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $86.56 | General |
| Category: CELLT | ||||||
| 09/26/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,270.15 | General |
| 09/05/2024 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $136.99 | General |
| Category: CELLT | ||||||
| 09/05/2024 | Incyte Corporation | — | Food and Beverage | Cash or cash equivalent | $17.18 | General |
| 08/26/2024 | Kite Pharma, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,210.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 184 | 406 | $114,824 | $38,539 |
| 2022 | 6 | 192 | 456 | $124,116 | $43,637 |
| 2021 | 2 | 30 | 72 | $16,230 | $6,073 |
Total Patients
406
Total Services
934
Medicare Billing
$88,248
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 61 | 181 | $57,521 | $19,596 | 34.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 82 | $13,120 | $4,968 | 37.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 42 | $13,314 | $4,590 | 34.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 36 | 54 | $12,690 | $3,938 | 31.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 18 | $8,064 | $2,451 | 30.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 15 | 15 | $6,825 | $2,132 | 31.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 14 | $3,290 | $864.71 | 26.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 50 | 178 | $56,426 | $20,553 | 36.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 34 | 130 | $20,800 | $7,369 | 35.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 39 | $12,795 | $4,697 | 36.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 41 | 54 | $12,930 | $3,968 | 30.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 21 | 22 | $9,856 | $3,204 | 32.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 16 | 16 | $7,280 | $2,418 | 33.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 16 | 17 | $4,029 | $1,428 | 35.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 18 | 30 | $9,510 | $3,614 | 38.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 12 | 42 | $6,720 | $2,459 | 36.6% |
About Dr. Leonard Alsfeld, M.D
Dr. Leonard Alsfeld, M.D is a Internal Medicine healthcare provider based in Charleston, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2013. The National Provider Identifier (NPI) number assigned to this provider is 1912346693.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leonard Alsfeld, M.D has received a total of $60,050 in payments from pharmaceutical and medical device companies, with $51,134 received in 2024. These payments were reported across 84 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($42,830).
As a Medicare-enrolled provider, Alsfeld has provided services to 406 Medicare beneficiaries, totaling 934 services with total Medicare billing of $88,248. Data is available for 3 years (2021–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Charleston, SC
- Active Since 06/17/2013
- Last Updated 06/17/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1912346693
Products in Payments
- Yescarta (Drug) $15,396
- JAKAFI (Drug) $7,409
- Vonjo (Drug) $3,192
- NIKTIMVO (Drug) $430.00
- ELIQUIS (Drug) $123.94
- CALQUENCE (Drug) $122.70
- CHANTIX (Drug) $120.97
- EMPLICITI (Biological) $119.11
- OPDIVO (Biological) $94.08
- DARZALEX (Biological) $76.19
- IMBRUVICA (Drug) $68.80
- Epkinly (Drug) $58.35
- BRUKINSA (Drug) $54.17
- TECVAYLI (Biological) $53.57
- Enhertu (Drug) $29.91
- KYMRIAH (Drug) $29.08
- MONJUVI (Drug) $24.40
- EPKINLY (Drug) $21.59
- CARVYKTI (Biological) $20.93
- VENCLEXTA (Drug) $15.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Charleston
William Chapman, Do, DO
Internal Medicine — Payments: $1.3M
Internal Medicine $1.3M
Dr. Ryan Tedford, M.d, M.D
Internal Medicine — Payments: $432,170
Internal Medicine $432,170
Harold Szerlip, Md, MD
Internal Medicine — Payments: $284,278
Internal Medicine $284,278
Dr. Nathan Shores, M.d, M.D
Internal Medicine — Payments: $262,570
Internal Medicine $262,570
Hamza Hashmi, M.d, M.D
Internal Medicine — Payments: $234,146
Internal Medicine $234,146
Dr. Anne Kroman, D.o., Phd, D.O., PHD
Internal Medicine — Payments: $202,518
Internal Medicine $202,518